| Name | Cvs Pharmacy #00642 |
|---|---|
| Organization Name | Rhode Island Cvs Pharmacy, L.l.c |
| Location | 767 Warwick Ave, Warwick, Rhode Island 02888 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (401) 467-7788 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
As prostate cancer is the third leading cause of cancer death in European men with more than 300,000 men being diagnosed every year, society needs to commit to changing the way the disease is viewed. Therefore a mini-symposium and lunch meeting are organized on 18 September 2009 in Antwerp on the occasion of the European launch of the Proactive Prostates Initiative, organized as part of Urology Week.
Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.
Knopp Neurosciences Inc. announced today that it has formed a new parent entity called Knopp Biosciences LLC to expand operations with the goal of becoming a more broadly integrated biopharmaceutical company.
Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for AVP-825.
› Verified 4 days ago
| NPI Number | 1003913500 |
| Organization Name | RHODE ISLAND CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 00642 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 767 Warwick Ave Warwick Ave Sc, Warwick, RI 02888 |
| Phone Number | 401-467-7788 |
News Archive
As prostate cancer is the third leading cause of cancer death in European men with more than 300,000 men being diagnosed every year, society needs to commit to changing the way the disease is viewed. Therefore a mini-symposium and lunch meeting are organized on 18 September 2009 in Antwerp on the occasion of the European launch of the Proactive Prostates Initiative, organized as part of Urology Week.
Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.
Knopp Neurosciences Inc. announced today that it has formed a new parent entity called Knopp Biosciences LLC to expand operations with the goal of becoming a more broadly integrated biopharmaceutical company.
Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for AVP-825.
› Verified 4 days ago
News Archive
As prostate cancer is the third leading cause of cancer death in European men with more than 300,000 men being diagnosed every year, society needs to commit to changing the way the disease is viewed. Therefore a mini-symposium and lunch meeting are organized on 18 September 2009 in Antwerp on the occasion of the European launch of the Proactive Prostates Initiative, organized as part of Urology Week.
Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.
Knopp Neurosciences Inc. announced today that it has formed a new parent entity called Knopp Biosciences LLC to expand operations with the goal of becoming a more broadly integrated biopharmaceutical company.
Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for AVP-825.
› Verified 4 days ago
Reliable Respiratory, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 400 Warwick Avenue, Warwick, Rhode Island 02888 Phone: (781) 551-3335 | |
Kent Home Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11 Knight St, Warwick, Rhode Island 02886 Phone: (401) 732-0022 | |
Cvs Pharmacy #00642 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 767 Warwick Ave, Warwick, Rhode Island 02888 Phone: (401) 467-7788 | |
Cvs Pharmacy #00733 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2400 Warwick Ave, Warwick, Rhode Island 02889 Phone: (401) 737-2305 | |
Cvs Pharmacy #00689 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2790 Post Rd, Warwick, Rhode Island 02886 Phone: (401) 739-3173 |